Cita APA

Weich, N., Ferri, C. A., Moiraghi, E. B., Bengió, R., Giere, I., Pavlovsky, C., . . . Fundia, A. F. (2016). TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome. Web

Citación estilo Chicago

Weich, Natalia, Cristian Alberto Ferri, Elena Beatriz Moiraghi, Raquel Bengió, Isabel Giere, Carolina Pavlovsky, Irene Beatriz Larripa, and Ariela Freya Fundia. TP53 Codon 72 Polymorphism Predicts Chronic Myeloid Leukemia Susceptibility and Treatment Outcome. 2016.

Cita MLA

Weich, Natalia, et al. TP53 Codon 72 Polymorphism Predicts Chronic Myeloid Leukemia Susceptibility and Treatment Outcome. 2016.